Last updated 8 days ago

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

1020 patients around the world
Available in Chile, United States
The protocol consists of 2 studies. Study 1 includes induction and maintenance treatment, and Study 2 includes only induction treatment. Each study has its own hypotheses and outcome measures that will be assessed independently.
Merck Sharp & Dohme LLC
2Research sites
1020Patients around the world
This study is for people with
Ulcerative colitis
Moderate/severe ulcerative colitis
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Sites
Centro de Estudios Clínicos e Investigaciones Médicas CeCim
Recruiting
Paseo Bulnes 79, oficina 27, Santiago, Región Metropolitana
Clinical Research Chile SpA
Recruiting
Beauchef 683, Valdivia, Los Ríos
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy